Clinical expert opinion on the role of elosulfase alfa in non-ambulatory individuals with Morquio A syndrome
This explorative study offers valuable insights into drivers of ERT use in non-ambulatory patients with Morquio A, its potential benefits, and strategies for monitoring treatment outcomes in clinical practice. These findings may guide patient management, optimize treatment, and inform future research for this population.
Authors
- Karolina M. Stępień (ORCID: https://orcid.org/0000-0003-0148-6332)
- P. Campeau
- Nicole Muschol (ORCID: https://orcid.org/0000-0003-4213-7294)
- Carolina FM De Souza
- Serap Hatice Kalkanoğlu Sivri
- Martha Solano
- Barbara K. Burton
- Christina Lampe
- Roberto Giugliani
Institutions
- Northwestern University (US)
- Lurie Children's Hospital (US)
- Universidade Federal do Rio Grande do Sul (BR)
- Universität Hamburg (DE)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Hospital de Clínicas de Porto Alegre (BR)
- Hospices Civils de Lyon (FR)
- Lysosomal and Rare Disorders Research and Treatment Center (US)
- University Medical Center Hamburg-Eppendorf (DE)
- Salford Royal Hospital (GB)
- Hacettepe University Hospital (TR)
- Institute of Cardiology (CO)
Publication Details
- Journal
- Molecular Genetics and Metabolism Reports
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1016/j.ymgmr.2026.101290
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00